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Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for diseases such as cystic fibrosis 
(CF) in immunocompromised individuals. Outcome of CF is abnormally thickened mucus that causes 
problems in patient’s respiratory system. This condition affects 2.5 million people in the UK alone with a high 
rate of mortality by the age of 40. Various methods of treatment to manage CF by dispersion and disassembly 
of biofilm have been intensively researched. Since as much as 80% of human bacterial infections are biofilm-
associated, many researchers have begun investigating therapies that specifically target the biofilm 
architecture, thereby dispersing the microbial cells into their more vulnerable, planktonic state. Amongst the 
current methods of controlling CF, biofilm dissociation by the use of a combination of an amino acid and an 
antibiotic has been investigated in this research. During this study, biofilm formation by P. aeruginosa PAO1 
was observed under aerobic conditions in Luria Broth and M63 minimal media at 37°C for a period of 24 
hours. The cultures were treated with two isomeric forms of tryptophan at different concentrations (1 mM, 4 
mM, and 8 mM). Dispersal and dissociation of the cells in all cultures were investigated and compared with the 
control after 24 hours. The D isomer of tryptophan at concentrations of 4 mM and 8 mM showed higher rate of 
dispersion in comparison to the L isomeric form and the control. The effect of tryptophan varied with the 
medium that was used for biofilm growth. Extracellular polymeric substances (EPS) were extracted from the 
treated and untreated biofilm and quantified for their main components. Biofilm treated with tryptophan and 
erythromycin resulted in nearly 70% loss of EPS components in comparison with the control after 5 days of 
growth.  
1. Introduction 
1.1 Pseudomonas aeruginosa and biofilm formation 
Pseudomonas aeruginosa possess the ability to communicate within the bacterial population through the 
secretion of chemical signals called autoinducers. Bacteria are able to use a wide range of molecules for 
signalling purposes such as fatty acids, peptides, and N-acylated homoserine lactones (AHLs). These are 
called autoinducer 2 (AI-2). As the concentration of an autoinducer increases the cell density increases 
relatively until it reaches a threshold concentration. The phenomenon by which bacterial communication takes 
place is known as quorum sensing (QS) (Hirakawa and Tomita, 2013; Palmer et al. 2013).  
QS controls processes such as bioluminescence, sporulation, antibiotic production, virulence factors, and 
biofilm formation (Rutherford and Bassler, 2012). Through expression of the specific signals, P. aeruginosa 
can control its virulence factors (Rice et al. 2008). Factors such as elastase, proteases, rhamnolipids and 
exotoxin A, pyoverdin, pyocyanin have been vastly studied (Rutherford and Bassler, 2012).  
Biofilm formation develops in series of stages. Firstly, the attachment of planktonic cells on a surface takes 
place where van der Waals forces form a weak reversible adhesion. Secondly, cells anchor themselves to the 
surfaces using pilli, at this stage cells begin to form a monolayer. This creates small clusters and upon 
reaching certain cellular density the biochemical signal molecules are produced and released, for example N- 
acylhomoserine lactone (AHLs). With the progression of colonisation, these form irreversible structures 
resistant to antimicrobials and disinfectants (Sharma, et al. 2014). After 8-24 hours, colonies form a stable 
attachment to the surface and to each other through secretion of extracellular polymeric substances (EPS) 
material that forms a sticky layer containing eDNA, proteins, carbohydrates and other cellular debris, which in 
turn protects colonised cells and promotes further growth of colonies (Pan et al. 2010). Changes in gene 
expression takes place upon the signalling molecules reaching the required threshold level. This in turn brings 
a phenotypic change from planktonic to biofilm forming sessile cells. The positive feedback loop is formed 
through synthesis of proteins (autoinducers) that is directly related to expression of QS. Finally, colonies reach 
maturation that leads to further dispersion of biofilm (Zalewska-Piatek et al. 2013). 
1.2 Medical relevance of biofilm formation  
Pseudomonas aeruginosa is an opportunistic bacterium that can cause acute and chronic infections especially 
in immunocompromised individuals. The most common infection that P. aeruginosa is responsible for is cystic 
fibrosis (CF) (Sharma, et al. 2014). CF is characterised by lowered pulmonary function and increased mortality 
(Rutherford and Bassler, 2012). Through the expression of QS by P. aeruginosa, thick condensed layer of 
biofilm forms, blocking pulmonary organs and as a result it leads to respiratory failure (Hirakawa and Tomita, 
2013). In the era where antibiotic resistance is a widespread problem, biofilm produced by number of 
microorganisms have been recognised as a potential target in development of new antimicrobial agents 
(Hirakawa and Tomita, 2013).  
P. aeruginosa express high antibiotic resistance to multiple antibiotics classes and it is difficult to eradicate 
(Poole, 2011). Resistance acquired by P. aeruginosa is due to chromosomal mutation and acquirement of 
resistance genes through horizontal gene transfer (Poole, 2011). Scientific literature describes number of 
quorum sensing inhibitors already in use. Despite the fact that P. aeruginosa is difficult to eliminate, studies 
show that novel therapies are being developed that combine amino acids and antibacterial compounds (She 
et al. 2015) to combat the rise in antibiotic resistance. Furthermore, scientific work suggests that macrolides 
class of antibiotic negates the effect of QS induced biofilm formation by P. aeruginosa (Tsang et al. 2003). 
Hence, for the purpose of this study, erythromycin was chosen.  
It has been reported that certain amino acids (Sanchez et al. 2013), cause biofilm dispersal and disassembly 
in bacteria, while lacking significant toxicity. The idea of targeting human pathogen such as P. aeruginosa with 
naturally occurring amino acid - tryptophan is a highly attractive idea. For the purpose of this study, 
dextrorotatory (D-) and laevorotatory (L-) isoforms of tryptophan have been chosen and three different 
concentrations (1 mM, 4 mM, 8 mM) selected to determine whether these concentrations have any effect on 
dispersion of P. aeruginosa PAO1 biofilm. Following that, combination of two isoforms of one concentration 
(the most effective one) of tryptophan and antibiotic erythromycin against P. aeruginosa PAO1 biofilm will be 
performed. The dispersal and inhibition activity of the biofilm dissociation treatment will be investigated. 
2. Materials and Methods 
2.1 Strain and media 
Pseudomonas aeruginosa PAO1 strain was obtained from bacterial culture collection at University of 
Westminster, London, UK. Mueller Hinton Agar (MH) was used for the maintenance of the P. aeruginosa 
PAO1 working stock. M63 minimal medium (pH was adjusted to pH 7 after addition of 1mL-L 1M MgSO4 and 
10 mL-L of 20% glycerol) Luria-Bertani Broth (LB) (pH was adjusted to 7.4) were used for biofilm growth. 
2.2 Biofilm quantification by Crystal violet assay 
For the determination of biofilm formation and subsequent application of biofilm dissociation treatment, 96-
microtiter plates were used. The general method of growing, staining and quantifying of biofilm was followed 
as described by O’Toole (2011). Each experiment was incubated in the same static conditions; 24 hours at 
37°C.  
2.3 Extraction of EPS from biofilm 
The extraction method followed was as published by Staats et al. (1999) with a slight modification. After the 
specific incubation time, the biofilm was scraped from the glass well walls using sterile techniques. The 
aliquots were then transferred to Eppendorf tubes and centrifuged at 3500 rpm for 30 min. After centrifugation, 
the supernatant containing dissolved carbohydrates and suspended protein was analysed after separation of 
bacterial cells.  
 
 
2.4 Colorimetric quantification of Carbohydrates and Protein content of EPS 
Bradford Assay was used to quantify proteins and the phenol-sulphuric acid assay as described by DuBois et 
al. (1956) was used to quantify carbohydrate content of the EPS extracted from the biofilm.  
2.5 Tryptophan and Erythromycin  
D- and L- isoforms of tryptophan were purchased from Sigma-Aldrich, UK. A working stock of 100 mM was 
prepared and diluted in Luria broth and M63 medium as required. Erythromycin was purchased from Sigma-
Aldrich, UK. A stock solution of 40 μg/mL was prepared and used as required.  
2.6 Biofilm dispersal treatment 
First set of experiment was quantifying the effect of three different concentrations (1 mM, 4 mM, 8 mM) of D-
and L- isoforms of tryptophan on biofilm formed by P. aeruginosa. Plates were incubated at 37°C for 24 hours. 
Biofilm staining and quantification was performed as described previously.  Second set of experiments 
examined the effect of erythromycin (4 µg/ml) combined with the mixture of D- and L- form of tryptophan on 
biofilm formation. Plates were left in the incubator at 37°C, 24 hours. Biofilm staining and quantifying was 
followed as described previously.  
2.7 Statistical analysis 
All experiments were carried out in triplicates and the statistical significance of each result was determined by 
one-way analysis of variance (ANOVA) through calculation of standard deviation from the mean and use of 
standard error. 
3. Results and discussion 
3.1 Tryptophan dispersal assay 
All of the constituents of the assay were loaded at the inoculation phase. The plates were then incubated for a 
period of 24 hours. After which, the biofilm was quantified by the crystal violet assay. Biofilm formation was 
tested with three increasing concentration (1 mM, 4 mM, and 8 mM) of the two isoforms of tryptophan. 
Growth in LB and M63 media are presented in Figure 1. The highest inhibition of biofilm formation was noted 
in D- form in 4 mM and 8 mM in comparisons to the L- form and the control. As the highest inhibition of biofilm 
was seen in samples containing D- isoform of tryptophan, this isoform was investigated further. 
 
Figure 1. Effect of D- and L- Tryptophan at various concentrations on biofilm formation and dispersal in 
comparison to the control after a period of 24 hours in LB medium (p <0.05; p=0.001) and M63 medium 
(p<0.05; p=0.001)  
The EPS extraction performed showed a decrease in carbohydrates content after treatment with 4 mM and 8 
mM tryptophan respectively. Additionally, the protein content was found to be lower than the control in 4 mM 
and 8 mM treatments. All the factors were found to inhibit formation of biofilm; this was most likely due to the 
media used. However, despite the minimal media factor, the high decrease was noted in 8 mM concentration 
in both D- and L- isoforms with similar decrease outcomes in 4 mM tryptophan. 
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3.2 Quantification of biofilm components 
Extraction assay performed on D- isoform samples for carbohydrates and proteins resulted in confirmation of 
the findings stated above. The 8 mM treatment showed ~80% decrease in carbohydrate content of the 
biofilm, while the 4mM treatment showed ~60% decrease. The proteins level decreased similarly with a ~ 
70% decrease after treatment with 8 mM and ~80% after treatment with 4 mM tryptophan. These findings 
correlated with the absorbance readings and suggests that biofilm forms weaker structures on minimal media. 
 
Figure 2. Quantification of carbohydrates and proteins extracted from P.aeruginosa biofilm after treatment with 
isomers of tryptophan and erythromycin and combination treatment. 
4. Discussion 
Biofilm development responds to the stress experienced by cells towards environmental changes, such as 
growth medium, where nutrients are limited, temperature, pH, and upon administration of antibiotics (Landini, 
2009). Therefore, two different media were tested to express stress factors on P. aeruginosa PAO1. Carbon 
source, salts, and metals ions influence the structure, size and growth rate of biofilm (Zalewska-Piatek et al. 
2013). M63 minimal medium consist of glycerol, which can serve as a carbon source for the growth of P. 
aeruginosa. Nitrogen, phosphorus and trace metals represents salts requirement for bacteria. Addition of 
magnesium sulphate promotes the enzymatic reaction required for DNA replication. Luria-Bertani medium 
containing tryptone that provides amino acids, yeast extract delivers vitamins and trace elements, while 
sodium is responsible for osmotic balance. 
The use of naturally occurring amino acid as a treatment of infection caused by bacteria is an interesting idea. 
Amino acids do not express any toxicity to the host while bacteria do not acquire resistance towards amino 
acids. Numerous Gram-positive and Gram-negative bacteria produce D- amino acids such as D- alanine and 
D- glutamic acid in a stationary phase and according to studies, D- amino acid are embedded in the 
peptidoglycan layer found in cell wall of bacteria (Barreteau, 2008). However, the amino acids are not 
produced in high volume to supress biofilm formation or cause biofilm dispersion (Kolodkin-Gal et al. 2010; 
She et al. 2015). Brandenburg et al. (2013) argues that some bacteria such as Bacillus subtilis, 
Staphylococcus aureus and Pseudomonas aeruginosa biofilms were sensitive to amino acid and caused 
partial inhibition of biofilm formation. During this experiment, D- and L- isoforms of tryptophan reacted 
differently on formed biofilm but not on cells morphology. 
Tryptophan caused dispersion and dissociation of biofilm. Furthermore, biofilm formed differently in different 
media that were used. P. aeruginosa PAO1 grown on LB, a rich media, formed a thick biofilm. However, when 
exposed to the L- isoform tryptophan, the loss in structure was noticed, while D- isoform caused higher rate of 
dispersion. The M63 biofilm control expressed different composition of biofilm in comparison to the LB control. 
According to the optical density, M63 displayed lower biofilm formation in comparison to the LB. As M63 is a 
minimal media and it is not as nutritious as LB, this explains the lower biofilm biomass.  
The antibiotic chosen for the purpose of this study was erythromycin, due to studies reporting suppression of 
Gram-negative bacteria virulence factors (Kawamura-Sato, et al. 2000). Erythromycin belongs to macrolides 
family of antibiotics where its mechanism of action blocks translation by binding to the 50S ribosomal subunit, 
mostly in Gram- positive organisms. However, P. aeruginosa PAO1 being a Gram- negative is resistant to 
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macrolides. A high MIC (erythromycin) of 512 µg/ml was found to effect P. aeruginosa PAO1 in Mueller – 
Hinton (Morita, et al. 2014). Nalca et al. (2006) reports that low dose of another type of macrolides – 
azithromycin 2 µg/ml had an effect on quorum-sensing autoinducers resulting in inhibition of P. aeruginosa 
PAO1 virulence factors. Study conducted by Tsang et al. (2003) suggests that erythromycin in low 
concentrations, such as the one chosen for this study 4 µg/ml affects P. aeruginosa cellular morphology 
through mechanism other than common antibiotic method which is disturbance of ribosomal action and 
subsequent inhibition of protein synthesis. This study confirms the changes in morphology as claimed by 
Tsang et al. (2003) of the cells observed after treatment of erythromycin. 
Another study investigating low dose of erythromycin applied to patients suffering from respiratory diseases 
caused by P. aeruginosa, resulted in overall reduction in sputum volume and increased lung function. 
However, the mechanism of action was confirmed not to be bacteriostatic, bactericidal or anti-inflammatory 
due to lack of changes in sputum densities consisting of leukocytes and pro-inflammatory mediators. These 
observations suggest that P. aeruginosa virulence factors are the main causatives of its virulence in CF 
(Tsang et al. 2003).  
Biofilm produced via QS is composed of an extra cellular matrix of which, the primamry components are 
carbohydrates, protein and eDNA (Yu et al., 2015; Sharma et al., 2014). It is accepted that the matrix protects 
bacteria from antagonistic factors such as antibiotics and as a results promotes chronic infection and 
resistance (Mah and O’Toole., 2001). One of the possible solutions to overcome this problem is to disperse 
the biofilm prior to treatment as represented in this study. Dispersal agent in synergy with an antibiotic could 
be a viable therapeutic treatment to combat/ eradicate biofilm mediated infections without the issue of 
antibiotic resistance. 
5. Conclusion 
P. aeruginosa PAO1 produces a number of virulence factors; pyocyanin, pyoverdine, and proteases are just 
few of them. It is believed that these work in synergy with each other when attacking human host organ such 
as lung tissue (Hosseinidoust, 2013). Pyoverdine is a siderophore expressed by P. aeruginosa as a virulence 
factor. Pyoverdine growth is affected by carbon sources available to the bacteria (Chiado et al. 2013). Another 
P. aeruginosa virulence factor, pyocyanin is often reported to be found in high concentrations in individuals 
suffering from CF. Quantifying the production of the virulence factors after the treatment in this research would 
be beneficial to fully confirm the hypothesis. However, amino acid used most likely does not affect P. 
aeruginosa virulence factors, whereas antibiotic do. By measuring the virulence factors of P. aeruginosa after 
the treatment, this would present either increase or decrease of the virulence factors through inhibition.  
Numerous studies show that P. aeruginosa cell morphology was modified upon treatment with different 
classes of antibiotics. To investigate what is causing the change or which part of bacterial cell wall component 
is affected, electron microscopy analysis of cell will need to be performed. Another experiment that can further 
validate findings from this study is minimal biofilm eradication concentration (MBEC). Sessile bacteria behave 
differently inside the host than in the laboratory conditions. The goal of the first part of the MBEC would be to 
find the concentration and time of tryptophan that disperse at least 75% of biofilm formed. Subsequently, 
planktonic cells can be treated with a known antibiotic that has a bactericidal effect on P. aeruginosa.  
Poor understanding of pathogenicity of P. aeruginosa and increasing antibiotic resistance is directly linked with 
lack of effective treatment for respiratory diseases such as cystic fibrosis caused by this microorganism. The 
findings from this study of the effects of tryptophan alone and in combination with erythromycin on biofilm 
formation could potentially have important implication for future research in cystic fibrosis.  
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